Atrial fibrillation: current treatment with anticoagulation
This indicator covers the percentage of patients who are currently treated with anticoagulation drug therapy in those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.
Last reviewed: November 2020
Next review: November 2025
This indicator will be reviewed using the assessment criteria in appendix B of the NICE indicators process guide when it reaches its review date or the underlying guidance is updated.
This indicator was previously published as NM82.
How to use NICE indicators and how we develop them
Indicators can be used in a number of different settings to support high quality care. These include:
- identifying where improvements are needed
- setting priorities for quality improvement and support
- creating local performance dashboards
- benchmarking performance against national data
- supporting local quality improvement schemes
- showing progress that local health systems are making on outcomes.
Find out how to use indicators and how we develop them.